Baillie Gifford & Co’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $44.5M | Sell |
|
|||||
|
2025
Q2 | $45.6M | Buy |
|
|||||
|
2025
Q1 | $42.1M | Sell |
|
|||||
|
2024
Q4 | $52.3M | Buy |
|
|||||
|
2024
Q3 | $13.8M | Sell |
|
|||||
|
2024
Q2 | $32.5M | Sell |
|
|||||
|
2024
Q1 | $37.9M | Sell |
|
|||||
|
2023
Q4 | $30.8M | Sell |
|
|||||
|
2023
Q3 | $30.5M | Sell |
|
|||||
|
2023
Q2 | $43.8M | Sell |
|
|||||
|
2023
Q1 | $38.7M | Buy |
|
|||||
|
2022
Q4 | $32.5M | Buy |
|
|||||
|
2022
Q3 | $35.7M | Buy |
|
|||||
|
2022
Q2 | $40M | Sell |
|
|||||
|
2022
Q1 | $50.1M | Sell |
|
|||||
|
2021
Q4 | $56.1M | Buy |
|
|||||
|
2021
Q3 | $47.7M | Buy |
|
|||||
|
2021
Q2 | $41.8M | Sell |
|
|||||
|
2021
Q1 | $33.9M | Buy |
|
|||||
|
2020
Q4 | $25.6M | Buy |
|
|||||
|
2020
Q3 | $20.2M | Buy |
|
|||||
|
2020
Q2 | $13.5M | Buy |
|
|||||
|
2020
Q1 | $214K | Sell |
|
|||||
|
2019
Q4 | $293K | Hold |
|
|||||
|
2019
Q3 | $276K | Sell |
|
|||||
|
2019
Q2 | $245K | Hold |
|
|||||
|
2019
Q1 | $254K | Hold |
|
|||||
|
2018
Q4 | $203K | Buy |
|